首页> 外文期刊>The journal of headache and pain >Acute pharmacotherapy of migraine, tension-type headache, and cluster headache
【24h】

Acute pharmacotherapy of migraine, tension-type headache, and cluster headache

机译:偏头痛,紧张型头痛和丛集性头痛的急性药物治疗

获取原文
       

摘要

In most migraine patients acute therapy is needed. Migraine can be treated either with specific drugs, the triptans and ergot alkaloids, or with NSAIDs. Triptans are a major step foreward in migraine therapy. The therapeutic gain for headache relief is 50% for subcutaneous sumatriptan whereas it is 30-40% for most oral triptans. After oral triptans sustained pain free is only 30%. There is thus still ample room for improvement of acute therapy in migraine. For tension-type headache there is no specific therapy and it is treated with NSAIDs. Only 17-32% become pain free after these drugs. For attacks of cluster headache oxygen and subcutaneous sumatriptan can be used. Intranasal triptans can be an alternative.
机译:在大多数偏头痛患者中,需要急性治疗。偏头痛可以用特定药物,曲坦类和麦角生物碱或NSAIDs治疗。 Triptans是偏头痛治疗的重要一步。皮下舒马曲坦缓解头痛的治疗效果为50%,而大多数口服曲普坦为30-40%。口服曲坦类药物后,持续的疼痛仅为30%。因此,偏头痛的急性治疗仍有很大的改善空间。对于紧张型头痛,没有特异性疗法,可以使用NSAIDs治疗。使用这些药物后,只有17-32%的人不会感到疼痛。对于发作性头痛,可以使用氧气和皮下舒马普坦。鼻内曲普坦可以替代。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号